Stable volume growth in specialty chemical segment The pharmaceutical segment posted flattish (-0.1% YoY) growth with 14.3% revenue contribution in Q4FY17. EBIT for the segment grew at 6% to Rs149mn with identical margin of ~12%. Since major fixed costs already built-in incremental volumes will result in significant increase in segment profits. We...